Atish Choudhury, MD, PhD

home / authors / atish-choudhury-md-phd

Articles

Recent Updates in Prostate Cancer Care

April 8th 2022

Dr Choudhury shares recent updates from 2021 meetings including ASCO GU, AUA, and ESMO.

Trends in Prostate Cancer Care

Bobby Liaw, MD;Atish Choudhury, MD, PhD

April 4th 2022

Prostate cancer experts share exciting changes to the prostate cancer treatment landscape and how we are now better equipped to take care of patients with prostate cancer.

Sequencing in mCSPC

Atish Choudhury, MD, PhD

March 23rd 2022

A prostate cancer expert shares rationale for his preferences and choices while sequencing therapies in prostate cancer.

Duration of Treatment for Patients with mCSPC

Atish Choudhury, MD, PhD;Bobby Liaw, MD

March 16th 2022

Dr Bobby Liaw talks about relationship between treatment duration, dosing and efficacy.

Safety Considerations in mCSPC and Selection of Androgen Receptor Pathway Inhibitors

Atish Choudhury, MD, PhD

March 10th 2022

Dr. Atish Choudhury discusses safety features to keep in mind when choosing androgen receptor pathway inhibitors.

Long-Term Data with Androgen Receptor Pathway Inhibitors

Atish Choudhury, MD, PhD

March 10th 2022

A prostate cancer expert shares long-term data with androgen receptor pathway inhibitors in mCSPC.

Treatment Options and Considerations in mCSPC

Atish Choudhury, MD, PhD

March 9th 2022

Dr. Choudhury discusses treatment considerations and treatment options for mCSPC.

Diagnosis and Management of mCSPC

Atish Choudhury, MD, PhD

December 22nd 2021

Dr. Atish Choudhury provides an overview of advances and changes in management of patients with metastatic castration sensitive prostate cancer (mCSPC) in the last decade.